From the Department of Surgery, University of Virginia, Charlottesville, Virginia, USA; and the Department of Surgery, Ruprecht-Karls University, Heidelberg, Germany.
Exp Clin Transplant. 2020 Jun;18(3):320-324. doi: 10.6002/ect.2019.0248. Epub 2020 Feb 7.
Spontaneous splenorenal shuntis a type of portosystemic shunt that develops frequently in the setting of chronic portal hypertension. It remains controversial whether shuntinterventions during liver transplant improve transplant outcomes.
We conducted a retrospective comparison between deceased-donor liver transplant recipients who received spontaneous splenorenal shunt intervention and those who did not at a tertiary center between 2012 and 2017. Primary outcomes of interest included intraoperative transfusion requirement, hospital length of stay, acute kidney injury posttransplant, portal vein thrombosis, thrombocytopenia, and 1-year graft and patient survival.
Of 268 liver transplant recipients, 50 (18.6%) had large spontaneous splenorenal shunts pretransplant, with 45 patients having available radiologic and outcome data. Nine of 45 patients (20%) received shunt intervention, including pretransplant balloonoccluded retrograde transvenous obliteration (n = 5), intraoperative ligation of the left renal vein (n = 3), and intraoperative direct shunt ligation (n = 1). Demographic data, clinical characteristics, and Model for End-Stage Liver Disease scores were not different between the intervention and the nonintervention groups. Intraoperative transfusion, length of hospitalization, portal vein thrombosis, thrombocytopenia, and 1-year graft and patient survival were also similar between the 2 groups. However, the rate of posttransplant acute kidney injury was significantly lower in patients in the intervention group (0 cases vs 12 cases; odds ratio = 0.73; 95% confidence interval, 0.59-0.90). Patients with no SRS intervention (n = 36) were followed radiologically for 1 year posttransplant, with follow-up data showing complete resolution of spontaneous splenorenal shunt in just 4 patients (15%) and no changes in the remaining patients.
Peritransplant interventions for spontaneous splenorenal shunt may reduce posttransplant acute kidney injury. In patients without intervention, spontaneous splenorenal shunt predominantly persisted 1 year posttransplant.
自发性脾肾分流是一种门体分流,在慢性门静脉高压症中经常发生。在肝移植过程中进行分流干预是否改善移植结果仍存在争议。
我们在 2012 年至 2017 年期间,在一家三级中心对接受和未接受自发性脾肾分流干预的已故供肝移植受者进行了回顾性比较。主要观察结果包括术中输血需求、住院时间、移植后急性肾损伤、门静脉血栓形成、血小板减少症以及 1 年移植物和患者存活率。
在 268 例肝移植受者中,50 例(18.6%)术前存在大的自发性脾肾分流,其中 45 例有可用的影像学和结果数据。45 例患者中有 9 例(20%)接受了分流干预,包括术前球囊阻塞逆行经静脉闭塞(n=5)、术中结扎左肾静脉(n=3)和术中直接分流结扎(n=1)。干预组和非干预组之间的人口统计学数据、临床特征和终末期肝病模型评分没有差异。术中输血、住院时间、门静脉血栓形成、血小板减少症以及 1 年移植物和患者存活率在两组之间也相似。然而,干预组患者的移植后急性肾损伤发生率显著降低(0 例与 12 例;比值比=0.73;95%置信区间,0.59-0.90)。未进行 SRS 干预的 36 例患者在移植后 1 年进行了影像学随访,随访数据显示 4 例(15%)患者的自发性脾肾分流完全缓解,其余患者无变化。
移植前干预自发性脾肾分流可能会减少移植后急性肾损伤。在未进行干预的患者中,1 年后主要发现自发性脾肾分流持续存在。